论文部分内容阅读
为认真贯彻国务院办公厅14号文件和上海市质量工作会议精神,上海医药工业销售公司和26家制剂生产厂在北京、上海、广州、郑州、成都、哈尔滨等36个城市开展的“上海新药质量千里行”活动,于7月18日同时拉开序幕。 针对当前医药行业同类产品重复生产多、销售中回扣风越演越烈的现状,上海医药工业销售公司和生产厂家共同开展的这次“上海新药质量千里行”活动,旨在广泛听取各地对上海药品质量和需求的意见,以促进上海医药产品质量和销售服务质量的提高,推进上海药品的名牌工程、放心工程和推荐活动,把目前依靠回扣促销的低水平竞争,积
In order to conscientiously implement the No. 14 document of the General Office of the State Council and the spirit of the Shanghai Quality Work Conference, the Shanghai Pharmaceutical Industry Sales Company and 26 pharmaceutical manufacturing plants have launched “Shanghai New Drug Quality” in 36 cities including Beijing, Shanghai, Guangzhou, Zhengzhou, Chengdu and Harbin. The “Thousand Miles” activity kicked off on July 18th. In response to the current situation where similar products in the pharmaceutical industry are repeatedly duplicated and the rebate in sales is becoming increasingly fierce, the “Shanghai New Drug Quality Thousand Miles” activity jointly developed by the Shanghai Pharmaceutical Industry Sales Company and the manufacturer aims to widely listen to the various places in Shanghai. Opinions on drug quality and demand to promote the improvement of Shanghai pharmaceutical product quality and sales service quality, advance brand-name projects, relief projects and recommended activities for Shanghai pharmaceuticals, and rely on low-level competitions that currently rely on kickback promotions.